Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
Conditions: Type 2 Diabetes Mellitus; Susceptibility, Genetic Interventions: Drug: GLP-1 receptor agonist; Drug: responders group and nonresponders group Sponsors: The Affiliated Hospital of Xuzhou Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Byetta | China Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Genetics | Hospitals | Research